NasdaqCM - Nasdaq Real Time Price USD

Beyond Air, Inc. (XAIR)

0.1950
-0.0011
(-0.56%)
At close: 4:00:02 PM EDT
0.1949
-0.00
(-0.05%)
After hours: 4:56:28 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for XAIR

Recent News: XAIR

View More
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
GlobeNewswire 18 days ago
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
GlobeNewswire 21 days ago
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire 27 days ago
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
GlobeNewswire last month
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders

NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders
GlobeNewswire last month
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
GlobeNewswire last month
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
GlobeNewswire last month
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH
GlobeNewswire 2 months ago
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences
GlobeNewswire 2 months ago
Beyond Air Third Quarter 2025 Earnings: Beats Expectations

Beyond Air Third Quarter 2025 Earnings: Beats Expectations
Simply Wall St. 2 months ago
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 2 months ago
View More

Related Tickers

DHAI DIH Holding US, Inc.
0.1739
-3.92%
 
AXDX Accelerate Diagnostics, Inc.
0.1341
-9.39%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.5600
-0.05%
 
TNON Tenon Medical, Inc.
1.3100
+15.93%
 
BMRA Biomerica, Inc.
3.5500
-0.84%
 
AIMD Ainos, Inc.
0.5499
+1.89%
 
RSLS ReShape Lifesciences Inc.
6.01
-9.76%
 
VTAK Catheter Precision, Inc.
0.2939
+2.76%
 
HYPR Hyperfine, Inc.
0.7300
-1.92%
 
TIVC Tivic Health Systems, Inc.
4.2300
+7.36%